Literature DB >> 23921497

Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.

Young-Hoon Joo1, Ie-Ryung Yoo, Kwang-Jae Cho, Jun-Ook Park, In-Chul Nam, Min-Sik Kim.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the prognostic factors of patients with pathologically negative lymph node (pN0) head and neck cancer. Study Design Case series with chart review.
SETTING: College medical center. SUBJECTS AND METHODS: The medical records of 120 patients were reviewed. Primary tumor sites included 46 larynx, 45 oral cavity, 17 oropharynx, and 12 hypopharynx.
RESULTS: The recurrence rate was 14% (17/120) over a mean observation period of 33 months. Median (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) maximal standardized uptake value (SUVmax; using 8.5 as a cutoff; P = .001), positive surgical margins (P = .005), and pathologic T stage (P = .012) were found to be associated with recurrence. The 5-year disease-specific survival rate (DSSR) in our cohort was 86%. Patients with an SUVmax value higher than 8.5 and positive surgical margins had significantly decreased 5-year DSSR based on Kaplan-Meier survival curves. Multivariate Cox regression analysis confirmed the significant association between median SUVmax (using 8.5 as a cutoff; hazard ratio [HR], 6.13; 95% confidence interval [CI], 1.79-20.93; P = .004) and margin involvement (HR, 4.98; 95% CI, 1.42-17.47; P = .012).
CONCLUSION: A median (18)F-FDG PET/CT SUVmax cutoff values of 8.5 or greater and positive surgical margins were associated with adverse outcomes in patients with pN0 head and neck cancer.

Entities:  

Keywords:  head and neck neoplasms; lymph node; neck dissection; squamous cell carcinoma; treatment outcome

Mesh:

Substances:

Year:  2013        PMID: 23921497     DOI: 10.1177/0194599813500630

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

Review 1.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

2.  Predictors of health-related quality of life in patients treated with neck dissection for head and neck cancer.

Authors:  Elise M Gane; Steven M McPhail; Anna L Hatton; Benedict J Panizza; Shaun P O'Leary
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-22       Impact factor: 2.503

3.  Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma.

Authors:  Jeffery B Jorgensen; Russell B Smith; Andrew Coughlin; William C Spanos; Michele M Lohr; Steven M Sperry; Oleg Militsakh; Robert P Zitsch; Bevan Yueh; Laura M Dooley; Aru Panwar; Tabitha L I Galloway; Nitin A Pagedar
Journal:  Otolaryngol Head Neck Surg       Date:  2018-08-21       Impact factor: 3.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.